Schizophrenia Researchers from the St. Louis University School of Medicine report that adjunctive N-acetylcysteine (NAC) may be effective in reducing negative and general symptoms in schizophrenia.
Background: Hyperhomocysteinaemia is an independent cardiovascular risk factor in patients with renal disease. The current study aimed to determine the effect of intravenous N-acetylcysteine on plasma ...
DEAR DR. ROACH: I’d like to have your thoughts on what value the NAC supplement may have for reducing cravings for marijuana or nicotine? I’m 73 and have been smoking marijuana daily since I was 21.
After 7 days of treatment in a randomized trial conducted in China, mean sputum viscosity scores declined by 0.24 points more with NAC than placebo injections (P<0.001), and scores for expectoration ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Patients' disease characteristics and demographic data at screening (T0) are reported in Table 1. At the screening visit (T0), CRP levels were higher than normal (=0.5 mg/dL) in 81 (66.4%) patients ( ...
How should N-acetylcysteine (Mucomyst) be used prophylactically for patients who have been diagnosed with chronic renal insufficiency and are undergoing cardiac catheterization? N-acetylcysteine is an ...
One of the only viable methods of increasing intracellular levels of the superantioxidant glutathione is supplementing with N-acetylcysteine (NAC), a prodrug for the amino acid cysteine. 1 Deficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results